Giuseppe Mameli Selected Research

Hashimoto Disease (Thyroiditis, Hashimoto)

1/2014

Detection of serum antibodies cross-reacting with Mycobacterium avium subspecies paratuberculosis and beta-cell antigen zinc transporter 8 homologous peptides in patients with high-risk proliferative diabetic retinopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giuseppe Mameli Research Topics

Disease

18	Multiple Sclerosis 10/2017 - 12/2003
3	Disease Progression 12/2018 - 01/2008
3	Infections 04/2016 - 01/2013
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2016 - 01/2014
2	Parkinson Disease (Parkinson's Disease) 12/2018 - 04/2016
2	Paratuberculosis (Johne's Disease) 03/2016 - 05/2014
2	Inflammation (Inflammations) 03/2016 - 01/2007
2	Acquired Immunodeficiency Syndrome (AIDS) 02/2007 - 04/2006
1	Huntington Disease (Huntington's Disease) 12/2018
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2018
1	Alzheimer Disease (Alzheimer's Disease) 12/2018
1	Neuromyelitis Optica (Devic's Disease) 10/2017
1	Virus Diseases (Viral Diseases) 01/2016
1	Rheumatoid Arthritis 09/2015
1	Thyroiditis 07/2015
1	Necrosis 11/2014
1	Hashimoto Disease (Thyroiditis, Hashimoto) 01/2014
1	Vitreous Hemorrhage 01/2014
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2014
1	Epstein-Barr Virus Infections 01/2013
1	Acute Disease 01/2013
1	Infectious Mononucleosis (Glandular Fever) 01/2013
1	Genetic Predisposition to Disease (Genetic Predisposition) 05/2007
1	Demyelinating Diseases (Demyelinating Disease) 01/2007

Drug/Important Bio-Agent (IBA)

8	Peptides (Polypeptides)IBA 10/2017 - 01/2014
6	AntibodiesIBA 09/2016 - 01/2014
6	EpitopesIBA 03/2016 - 01/2014
4	Proteins (Proteins, Gene)FDA Link 04/2016 - 01/2013
4	syncytinIBA 11/2014 - 05/2007
3	Biomarkers (Surrogate Marker)IBA 12/2018 - 01/2008
3	AntigensIBA 10/2017 - 01/2014
3	Natalizumab (Tysabri)FDA Link 01/2016 - 02/2014
2	MicroRNAs (MicroRNA)IBA 12/2018 - 01/2016
2	Glycoproteins (Glycoprotein)IBA 10/2017 - 05/2007
2	InterferonsIBA 09/2016 - 01/2008
2	Myelin Basic ProteinIBA 03/2016 - 05/2014
2	ProinsulinIBA 02/2016 - 05/2015
2	DNA (Deoxyribonucleic Acid)IBA 09/2015 - 10/2009
2	EBV-encoded nuclear antigen 1IBA 11/2013 - 01/2013
2	Immunoglobulin G (IgG)IBA 11/2013 - 01/2013
2	env Gene ProductsIBA 10/2009 - 01/2007
2	CytokinesIBA 05/2007 - 12/2003
1	Interferon Regulatory FactorsIBA 03/2016
1	B-Cell Activating FactorIBA 01/2016
1	gamma-delta T-Cell Antigen Receptors (T-Cell Receptor delta-Chain)IBA 02/2014
1	Retinaldehyde (Retinal)IBA 01/2014
1	Zinc Transporter 8IBA 01/2014
1	Messenger RNA (mRNA)IBA 01/2013
1	Epstein-Barr Virus Nuclear AntigensIBA 01/2013
1	RNA (Ribonucleic Acid)IBA 10/2009
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2008
1	Interferon-betaIBA 01/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2007
1	CCAAT-Enhancer-Binding Protein-betaIBA 02/2007
1	Proteasome Endopeptidase Complex (Proteasome)IBA 04/2006

Therapy/Procedure

6	Therapeutics 12/2018 - 01/2008